Brand Name | Status | Last Update |
---|---|---|
3.6oz biest 2.5 estrogen cream | unapproved drug other | 2025-06-01 |
advanced formula estro-life | unapproved drug other | 2022-03-31 |
arthcal estriol face cream for women | C200263 | 2025-02-28 |
balance plus cream | unapproved drug other | 2025-06-01 |
biest 2.5 estrogen cream | unapproved drug other | 2021-06-21 |
biest 2.5 estrogen cream (lavender scented) | unapproved drug other | 2021-06-21 |
biest 5.0 estrogen cream | unapproved drug other | 2025-06-01 |
biest 5.0 estrogen cream - 3.6oz | unapproved drug other | 2025-06-01 |
estriol 5.0 cream | unapproved drug other | 2025-06-01 |
estro-life | unapproved drug other | 2022-03-31 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Atrophy | D001284 | — | — | — | 1 | — | — | — | 1 |
Atrophic vaginitis | D059268 | EFO_1001271 | — | — | 1 | — | — | — | 1 |
Drug common name | Estriol |
INN | _ |
Description | Estriol is a 3-hydroxy steroid that is estra-1,3,5(10)-trien-3-ol substituted by additional hydroxy groups at positions 16 and 17 (16alpha,17beta-stereoisomer). It has a role as an estrogen, a human metabolite, a human xenobiotic metabolite and a mouse metabolite. It is a 3-hydroxy steroid, a 16alpha-hydroxy steroid and a 17beta-hydroxy steroid. It derives from a hydride of an estrane. |
Classification | Small molecule |
Drug class | estrogens |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O |
PDB | — |
CAS-ID | 50-27-1 |
RxCUI | — |
ChEMBL ID | CHEMBL193482 |
ChEBI ID | 27974 |
PubChem CID | 5756 |
DrugBank | DB04573 |
UNII ID | FQ5FV85BS0 (ChemIDplus, GSRS) |